At the beginning of the pandemic, only a nose swab test could detect Covid-19 infection in the body. It was painful and scary Then the RTK test began to be used with high accuracy before the breath test and cough sound analysis were also produced. ResApp, an application developed by an Australian firm can detect Covid019 patients by analyzing cough sounds with 92% accuracy.
With success at the clinical level, ResApp was bought by the giant pharmaceutical firm Pfizer for AUD 179 million (~RM539 million). In addition to detecting Covid-19, the ResApp algorithm can also detect various types of repertory such as asthma, pneumonia, and bronchitis.
Pfizer hopes that this application will be used around the world to detect patients faster without having to do chemical tests like the one that costs money. The developers hope that with it now being taken over by Pfizer, the use of the application can be expanded to rural areas to facilitate the detection of pulmonary diseases quickly and cheaply.
Tags
APPS & GAMES